115 related articles for article (PubMed ID: 21224702)
1. [A case of stage IV breast cancer with bone metastases that responded well for long-term to hormonal therapy].
Oda G; Nakagawa T; Sato T; Kuwayama T; Yamamoto K; Kawachi H; Kubota K; Sugihara K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2753-5. PubMed ID: 21224702
[TBL] [Abstract][Full Text] [Related]
2. Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial.
Kurosumi M; Takatsuka Y; Watanabe T; Imoto S; Inaji H; Tsuda H; Akiyama F; Sakamoto G; Ikeda T; Noguchi S
J Cancer Res Clin Oncol; 2008 Jun; 134(6):715-22. PubMed ID: 18075758
[TBL] [Abstract][Full Text] [Related]
3. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
[TBL] [Abstract][Full Text] [Related]
4. Focus on anastrozole and breast cancer.
Mokbel K
Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
[TBL] [Abstract][Full Text] [Related]
5. [A case of inflammatory breast cancer responding to anastrozole].
Sato T; Nakagawa T; Kuwayama T; Kubota K; Suzuki S; Sugihara K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2477-9. PubMed ID: 20037461
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant endocrine therapy with anastrozole significantly downstaged an elderly breast cancer woman with locally-advanced breast cancer which became operable].
Rai Y; Ando M; Sagara Y; Takahama T; Matsuyama Y; Ooi Y; Sagara Y
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1301-5. PubMed ID: 16184928
[TBL] [Abstract][Full Text] [Related]
7. [Advanced breast cancer in a patient achieving long-term SD after letrozole administration for liver metastasis developing during anastrozole therapy].
Ichinose Y; Kobayashi T; Fujimoto A; Uchida S; Sasaoki T; Goto K
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2913-6. PubMed ID: 21160269
[TBL] [Abstract][Full Text] [Related]
8. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
Novoa Vargas A; Font López KC; Amador DD
Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
[TBL] [Abstract][Full Text] [Related]
9. [Advanced breast cancer with lung and pleural metastases responsive to anastrozole--a case report].
Sakurai T; Oura S; Kinoshita T; Yokochi H; Enomoto K; Nishimura M; Okamura Y
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1607-10. PubMed ID: 12355946
[TBL] [Abstract][Full Text] [Related]
10. Endocrine options for breast cancer treatment: looking beyond tamoxifen.
Watanabe T; Sonoo H
Breast Cancer; 2000; 7(4):345-9. PubMed ID: 11114863
[No Abstract] [Full Text] [Related]
11. Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study.
Milla-Santos A; Milla L; Portella J; Rallo L; Pons M; Rodes E; Casanovas J; Puig-Gali M
Am J Clin Oncol; 2003 Jun; 26(3):317-22. PubMed ID: 12796608
[TBL] [Abstract][Full Text] [Related]
12. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
13. [A successful case of a super-elderly breast cancer patient treated with hormone therapy].
Aomatsu N; Kashiwagi S; Asano Y; Morisaki T; Nakamura M; Kawajiri H; Takashima T; Onoda N; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2042-4. PubMed ID: 23267970
[TBL] [Abstract][Full Text] [Related]
14. Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial.
Thürlimann B; Hess D; Köberle D; Senn I; Ballabeni P; Pagani O; Perey L; Aebi S; Rochlitz C; Goldhirsch A
Breast Cancer Res Treat; 2004 Jun; 85(3):247-54. PubMed ID: 15111763
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Ganz PA; Cecchini RS; Julian TB; Margolese RG; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):857-65. PubMed ID: 26686960
[TBL] [Abstract][Full Text] [Related]
16. Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial.
Aihara T; Yokota I; Hozumi Y; Aogi K; Iwata H; Tamura M; Fukuuchi A; Makino H; Kim R; Andoh M; Tsugawa K; Ohno S; Yamaguchi T; Ohashi Y; Watanabe T; Takatsuka Y; Mukai H
Breast Cancer Res Treat; 2014 Nov; 148(2):337-43. PubMed ID: 25318924
[TBL] [Abstract][Full Text] [Related]
17. Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial.
Mattar A; Logullo AF; Facina G; Nonogaki S; Soares FA; Gebrim LH
J Cancer Res Clin Oncol; 2011 May; 137(5):897-905. PubMed ID: 20886231
[TBL] [Abstract][Full Text] [Related]
18. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
Calzada L; Salazar EL; Pedron Nuevo N
Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
[TBL] [Abstract][Full Text] [Related]
19. [AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer].
Longo F; Mansueto G
Tumori; 2004; 90(6):1-12. PubMed ID: 15762372
[No Abstract] [Full Text] [Related]
20. Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.
Iwata H; Masuda N; Sagara Y; Kinoshita T; Nakamura S; Yanagita Y; Nishimura R; Iwase H; Kamigaki S; Takei H; Tsuda H; Hayashi N; Noguchi S
Cancer; 2013 Feb; 119(4):704-13. PubMed ID: 22972694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
